Can Listening to Music Improve Attention and Language After Post-Stroke Aphasia? (NCT07198048) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Can Listening to Music Improve Attention and Language After Post-Stroke Aphasia?
45 participantsStarted 2025-10
Plain-language summary
The goal of this clinical trial is to learn if a music-based intervention can acutely improve three types of attention (alerting, orientating, executive control) in people with aphasia following a stroke.
The main questions it aims to answer are:
1. Is a music based intervention effective at improving attention with someone who has aphasia?
2. Does music-induced changes in attention improve language abilities and quality of life with someone who has aphasia? Researchers will compare a group that listening to music, to listing to an audiobook group, to a group that serves as a control to see if there are changes in attention over time.
Participants will:
1. Listen to music or an audiobook for 30 minutes a day for 8 weeks
2. Complete a daily journal about each day's listening experience
3. Complete three testing sessions where attention, language, and quality of life are assessed.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Adults at least 18 years of age Individuals who have had a stroke and are at least 6 month post stroke Individuals are able to answer 4 questions to determine ability to consent (What is your name, what is the day/date, where are you , and why are we having this conversation).
Have normal or corrected to normal hearing Have normal or corrected to normal vision Have no issues with color blindness Individuals who have at least mild aphasia on the Western Aphasia Battery Revised Speaks American English
Exclusion Criteria:
Individuals who meet the inclusion criteria, but are unwilling to travel to the ABC Lab at Purdue University for in person testing and do not have a laptop or desktop with a web camera that they could participate online with, will be excluded.
Individuals who have had a dementia diagnosis or attention disorder pre stroke will be excluded.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in attention from T1 to T2 and T3
Timeframe: From T1 to T2 (11 weeks for the experimental and active control arms, 9 weeks for the no-contact arm) and to T3 (8 weeks after T2)
2
Change in language from T1 to T2 and T3
Timeframe: From T1 to T2 (11 weeks for the experimental and active control arms, 9 weeks for the no-contact arm) and to T3 (8 weeks after T2)
3
Changes in quality of life from T1 to T2 and T3
Timeframe: From T1 to T2 (11 weeks for the experimental and active control arms, 9 weeks for the no-contact arm) and to T3 (8 weeks after T2)